AstraZeneca

Thumbnail for EMA greenlights approval of AstraZeneca’s Voydeya for PNH treatment

27 February 2024

EMA greenlights approval of AstraZeneca’s Voydeya for PNH treatment

Thumbnail for AstraZeneca completes Icosavax acquisition for US$1.1B

21 February 2024

AstraZeneca completes Icosavax acquisition for US$1.1B

Thumbnail for AstraZeneca’s new US$300M facility sets stage for cutting-edge cell therapy advancements in US

8 February 2024

AstraZeneca’s new US$300M facility sets stage for cutting-edge cell therapy advancements in US

Thumbnail for AstraZeneca India, Roche ink breast cancer diagnostics partnership

14 December 2023

AstraZeneca India, Roche ink breast cancer diagnostics partnership

Thumbnail for AstraZeneca bolsters vaccine portfolio with US$1.1 billion Icosavax acquisition

13 December 2023

AstraZeneca bolsters vaccine portfolio with US$1.1 billion Icosavax acquisition

Thumbnail for Jordan’s MoH, AstraZeneca partner to develop green hospital projects

5 December 2023

Jordan’s MoH, AstraZeneca partner to develop green hospital projects

Thumbnail for AstraZeneca launches Evinova, a health-tech venture revolutionizing clinical trials

21 November 2023

AstraZeneca launches Evinova, a health-tech venture revolutionizing clinical trials

Thumbnail for AstraZeneca shuts down Bangalore plant amid global manufacturing review

20 November 2023

AstraZeneca shuts down Bangalore plant amid global manufacturing review

Thumbnail for AstraZeneca leverages biopharmaceutical expertise to revolutionize renewable energy production

19 November 2023

AstraZeneca leverages biopharmaceutical expertise to revolutionize renewable energy production

Thumbnail for CDC addresses RSV drug shortage, releases 77,000 doses amid rising cases

19 November 2023

CDC addresses RSV drug shortage, releases 77,000 doses amid rising cases